Evaluation of the Efficacy and Safety of a Dietary Supplement on Hair and Skin Aging in Subjects with Androgenic Alopecia

The study investigates the efficacy and safety of the dietary supplement NOVASTYNE® Glow on hair and skin health in 66 participants with androgenic alopecia, aged 33 to 67. Conducted over 84 days, the study assesses hair growth, brightness, and density, as well as skin moisturization, elasticity, and firmness, with evaluations at 28, 56, and 84 days. Participants were required to cease any anti-hair loss treatments 3 months prior and avoid products affecting hair growth during the study. The supplement aims to increase anagen phase hair count, reduce shedding, and enhance skin conditions, with potential benefits and mild to moderate risks. The study is ongoing, with results expected to be published by March 31, 2026.